Orally delivered biodegradable targeted inflammation resolving pectin-coated nanoparticles induce anastomotic healing post intestinal surgery
Open Access
- 25 November 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-11
Abstract
Targeted perioperative therapeutics supporting anastomotic healing during colitis are an urgent medical need. This study aimed to develop and evaluate a novel nanoparticle (NP)-based drug delivery system for improving anastomotic healing in Inflammatory bowel disease (IBD) patients following surgery. We developed pectin-coated polymeric NPs encapsulating the inflammation-resolving peptide Ac2-26. These NPs are designed to survive gastric passage, facilitate localized release in the colon via microbial pectinase degradation, and bind to the intestinal wound through collagen IV targeting. We investigated these NPs in a murine surgical model combining intestinal anastomosis with preoperative colitis induction. Perioperative administration of pectin-chitosan coated NPs containing Ac2-26 (P-C-Col IV-Ac2-26-NP) reduced colitis activity postoperatively. Macroscopic wound closure improved, as evaluated by endoscopy and intraabdominal adhesion scoring. Microscopic analysis revealed an improved semiquantitative healing score in the treatment group. This proof-of-concept study demonstrates that novel P-C-Col IV-Ac2-26-NP could be a promising and clinically feasible perioperative treatment strategy for IBD patients undergoing intestinal surgery. The targeted delivery system shows potential for enhancing anastomotic healing and reducing postoperative complications in this IBD patient population.Keywords
All Related Versions
Funding Information
- Lundbeck Foundation (R215-2015-4190, R215-2015-4190)
- Deutsche Forschungsgemeinschaft (1834/2-1, 1834/2-1)
This publication has 35 references indexed in Scilit:
- An Investigation into the Digestion of Chitosan (Noncrosslinked and Crosslinked) by Human Colonic BacteriaJournal of Pharmaceutical Sciences, 2008
- Nanomedicine: Developing smarter therapeutic and diagnostic modalities☆Advanced Drug Delivery Reviews, 2006
- Spatial and Temporal Profiles for Anti-Inflammatory Gene Expression in Leukocytes during a Resolving Model of PeritonitisThe Journal of Immunology, 2006
- Critical Protective Role for Annexin 1 Gene Expression in the Endotoxemic Murine MicrocirculationThe American Journal of Pathology, 2005
- Polymeric Nanoparticles for Oral Delivery of Drugs and Vaccines: A Critical Evaluation of In Vivo StudiesCritical Reviews™ in Therapeutic Drug Carrier Systems, 2005
- Modulation of inflammation and response to dexamethasone by Annexin 1 in antigen‐induced arthritisArthritis & Rheumatism, 2004
- Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptorNature Medicine, 2002
- Annexin 1 peptides protect against experimental myocardial ischemia‐reperfusion: analysis of their mechanism of actionThe FASEB Journal, 2001
- Lipocortin 1 and Chemokine Modulation of Granulocyte and Monocyte Accumulation in Experimental InflammationGeneral Pharmacology: The Vascular System, 1998
- Effects of chronic corticosteroids and vitamin a on the healing of intestinal anastomosesThe American Journal of Surgery, 1992